Effects of typical and atypical antipsychotic drugs on rat brain muscarinic receptors

Neurochemical Research

Volumn 32, Issue 3, 2007, Pages 525-532

  Zavitsanou, Katerina ^a,b   Nguyen, Vu H ^a   Han, Mei ^c   Huang, Xu Feng ^b,c  

^a AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^b Neuroscience Institute of Schizophrenia and Allied Disorders   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Amygdala; Autoradiography; Binding; Clozapine; Haloperidol; Hippocampus; Muscarinic receptors; Olanzapine; Schizophrenia; Typical and atypical antipsychotics

Indexed keywords

CLOZAPINE; HALOPERIDOL; MUSCARINIC RECEPTOR; OLANZAPINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; HIPPOCAMPUS; LIMBIC CORTEX; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; CLOZAPINE; FEMALE; HALOPERIDOL; ORGAN SPECIFICITY; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; REFERENCE VALUES;

ANIMALIA; RATTUS;

EID: 33847131931     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9266-9     Document Type: Article

References (33)

1. Weickert TW, Goldberg TE (2005) First- and Second-generation Antipsychotic Medication and Cognitive Processing in Schizophrenia. Curr Psychiatry Rev 7:304-310
2. Perry E, Walker M, Grace J et al (1999) Acetylcholine in mind: A neurotransmitter correlate of consciousness? Trends Neurosci 22:273-280
3. Winkler J, Suhr ST, Gage FH et al (1995) Essential role of neocortical acetylcholine in spatial memory. Nature 375:484-487
4. Mash DC, White WF, Mesulam MM (1988) Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex. J Comp Neurol 278:265-274
5. Levey AI, Kitt CA, Simonds WF et al (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype specific antibodies. J Neurosci 10:3218-3226
6. Mrzljak L, Levey AI, Goldman-Rakic PS (1993) Association of M1 and M2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission, Proc Natl Acad Sci USA. 90:5194-5198
7. Hyde TM, Crook JM (2001) Cholinergic systems and schizophrenia: primary pathology or epiphenomena? J Chem Neuroanat 22:53-63
8. Kinon BJ, Liberman JA (1996) Mechanisms of action of atypical antipsychotic drugs: A critical analysis. Psychopharmacol 124:2-34
9. Remington G, Kapur S (2000) Atypical antipsychotics are some more atypical than others? Psychopharmacol 148:3-15
10. Dean B, Crook JN, Opeskin K et al (1996) The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Mol Psychiatry 1:54-58
11. Crook JM, Tomaskovic-Crook E, Copolov DL et al (2000) Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation. Biol Psychiatry 48:381-388
12. Crook JM, Tomaskovic-Crook E, Copolov DL et al (2001) Decreased muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46, and the effects of neuroleptic drug treatment. Am J Psychiatry 158:918-925
13. Zavitsanou K, Katsifis A, Mattner F et al (2004) Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacol 29:619-625
14. Deng C, Huang XF (2005) Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia. J Neurosci Res 81:883-890
15. Crook JM, Dean B, Pavey G et al (1999) The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia. Life Sci 64:1761-1771
16. Zavitsanou K, Nguyen VH, Han M et al (2006) Effects of typical and atypical antipsychotic drugs on rat brain muscarinic receptors, Proceedings of the 26th Annual Meeting of the Australian Neuroscience Society, ISSN No 1034-3237 17:104
17. Huang XF, Deng C, Zavitsanou K (2006) Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats. Neuropeptides 40:213-219
18. Paxinos G, Watson C (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego
19. Zavitsanou K, Katsifis A, YuYet al (2005) M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders. Brain Res Bull 65:397-403
20. Bymaster FP, Calligaro DO, Falcone JF et al (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacol 14:87-96
21. Tandon R (1999) Cholinergic aspects of schizophrenia. Br J Psychiatry Suppl 37:7-11
22. Bymaster FP, Felder CC, Tzavara E et al (2003) Muscarinic mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27:1125-1143
23. Bernard V, Normand E, Bloch B (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neurosci 12:3591-3600
24. Levey AI (1993) Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52:441-448
25. Richelson E, Nelson A (1984) Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol 103:197-204
26. Wander TJ, Nelson A, Okazaki H et al (1987) Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro. Eur J Pharmacol 143:279-282
27. Kanba S, Suzuki E, Nomura S et al (1994) Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci 19:265-269
28. Schmitt A, May B, Muller B et al (2003a) Effects of Chronic Haloperidol and Clozapine Treatment on AMPA and kainite Receptor Binding in Rat Brain. Pharmacopsychiatry 36:292-296
29. Schmitt A, Zink M, Muller B et al (2003b) Effects of Long-Term Antipsychotic Treatment on NMDA Receptor Binding and Gene Expression of Subunits. Neurochem Res 28:235-241
30. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacol 26:283-594
31. Aggleton JP (1992) Neurobiological aspects of emotion, memory and mental dysfunctions. In: Aggleton JP (eds) The amygdale. Wiley-Liss, New York, pp 255-306
32. Buckley NJ, Bonner TI, Buckley CM et al (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469-476
33. Flynn DD, Mash DC (1993) Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2 and M3 muscarinic receptor subtypes in primate brain. Synapse 14:283-296